ADVFN Logo
Boards:
    Quotes:
      Boards
      News
      Market Data
      Markets
      Discover
      Subscribe Login/Register Profile Icon
      S&P 500
      5,431.60
      -0.04%
      US Tech 100
      19,168.00
      0.52%
      Dow Jones
      38,589.16
      -0.15%
      Brent Oil
      82.275
      0.00%
      Bitcoin
      66,549.78
      0.54%
      Registration Strip Icon for default Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.
      Get Started
      1. Home
      2. Investing
      3. Stocks
      4. USA
      5. NASDAQ
      6. Jazz Pharmaceuticals PLC (JAZZ)

      7. Jazz Pharmaceuticals PLC (JAZZ) News

      JAZZ

      Jazz Pharmaceuticals (JAZZ)

      Jazz Pharmaceuticals PLC
      		Date:
      Sort by:
       Showing the most relevant articles for your search:NASDAQ:JAZZ
      DateTimeSourceHeadlineSymbolCompany
      06/14/20244:12PMEdgar (US Regulatory)Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) materialNASDAQ:JAZZJazz Pharmaceuticals PLC
      06/14/20244:11PMEdgar (US Regulatory)Form DEF 14A - Other definitive proxy statementsNASDAQ:JAZZJazz Pharmaceuticals PLC
      06/11/20248:15PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:JAZZJazz Pharmaceuticals PLC
      06/07/20244:44PMEdgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:JAZZJazz Pharmaceuticals PLC
      06/03/20244:28PMEdgar (US Regulatory)Form PRE 14A - Other preliminary proxy statementsNASDAQ:JAZZJazz Pharmaceuticals PLC
      06/01/20248:05AMPR Newswire (US)Jazz Pharmaceuticals Presents Overall Survival and Longer Follow-Up Data from HERIZON-BTC-01 Trial Evaluating Zanidatamab in Previously Treated HER2-Positive Biliary Tract Cancer at ASCO 2024NASDAQ:JAZZJazz Pharmaceuticals PLC
      05/31/20245:01PMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:JAZZJazz Pharmaceuticals PLC
      05/30/20247:30AMPR Newswire (US)Jazz Pharmaceuticals Showcases Pioneering Research in Sleep Medicine at SLEEP 2024NASDAQ:JAZZJazz Pharmaceuticals PLC
      05/29/20244:15PMPR Newswire (US)Jazz Pharmaceuticals to Participate in Upcoming June Investor ConferencesNASDAQ:JAZZJazz Pharmaceuticals PLC
      05/29/20244:15PMPR Newswire (US)Jazz Pharmaceuticals to Participate in Upcoming June Investor ConferencesNASDAQ:JAZZJazz Pharmaceuticals PLC
      05/29/20247:45AMPR Newswire (US)Zanidatamab Granted Priority Review for HER2-Positive Metastatic Biliary Tract CancerNASDAQ:JAZZJazz Pharmaceuticals PLC
      05/22/20248:00AMPR Newswire (US)Jazz Pharmaceuticals Announces Collaboration with Life Science Cares to Improve the Wellbeing of Under Resourced Communities through Employee VolunteerismNASDAQ:JAZZJazz Pharmaceuticals PLC
      05/07/20245:31PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:JAZZJazz Pharmaceuticals PLC
      05/01/20244:10PMPR Newswire (US)Jazz Pharmaceuticals to Participate in the BofA Securities 2024 Health Care ConferenceNASDAQ:JAZZJazz Pharmaceuticals PLC
      05/01/20244:10PMPR Newswire (US)Jazz Pharmaceuticals to Participate in the BofA Securities 2024 Health Care ConferenceNASDAQ:JAZZJazz Pharmaceuticals PLC
      05/01/20244:05PMPR Newswire (US)Jazz Pharmaceuticals Announces First Quarter 2024 Financial Results and Affirms 2024 Financial GuidanceNASDAQ:JAZZJazz Pharmaceuticals PLC
      04/24/20244:05PMPR Newswire (US)Jazz Pharmaceuticals to Present Data Across Growing Oncology Pipeline and Portfolio at ASCO 2024NASDAQ:JAZZJazz Pharmaceuticals PLC
      04/17/20244:15PMPR Newswire (US)Jazz Pharmaceuticals to Report 2024 First Quarter Financial Results on May 1, 2024NASDAQ:JAZZJazz Pharmaceuticals PLC
      04/10/20247:45AMPR Newswire (US)Jazz Pharmaceuticals to Showcase Expansive Neuroscience Portfolio at American Academy of Neurology Annual MeetingNASDAQ:JAZZJazz Pharmaceuticals PLC
      04/02/20247:30AMPR Newswire (US)Jazz Pharmaceuticals Completes Zanidatamab Biologics License Application for Previously Treated HER2-Positive Metastatic Biliary Tract CancerNASDAQ:JAZZJazz Pharmaceuticals PLC
      03/12/20244:15PMPR Newswire (US)Jazz Pharmaceuticals to Host Virtual Zanidatamab R&D Day on Tuesday, March 19, 2024NASDAQ:JAZZJazz Pharmaceuticals PLC
      03/12/20244:15PMPR Newswire (US)Jazz Pharmaceuticals to Host Virtual Zanidatamab R&D Day on Tuesday, March 19, 2024NASDAQ:JAZZJazz Pharmaceuticals PLC
      03/08/20246:07PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:JAZZJazz Pharmaceuticals PLC
      03/07/20249:53PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:JAZZJazz Pharmaceuticals PLC
      03/07/20249:49PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:JAZZJazz Pharmaceuticals PLC
      03/07/20249:48PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:JAZZJazz Pharmaceuticals PLC
      03/07/20249:47PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:JAZZJazz Pharmaceuticals PLC
      03/07/20246:09PMEdgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:JAZZJazz Pharmaceuticals PLC
      03/05/20247:58PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:JAZZJazz Pharmaceuticals PLC
      03/05/20247:54PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:JAZZJazz Pharmaceuticals PLC
       Showing the most relevant articles for your search:NASDAQ:JAZZ